标题
Comparative Efficacy of Biologics in Psoriasis
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 13, Issue 6, Pages 365-374
出版商
Springer Nature
发表日期
2012-09-12
DOI
10.2165/11633110-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension
- (2012) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists
- (2011) Victoria L. Williams et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
- (2011) Namita Kothary et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities
- (2010) Alexa B. Kimball et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Can early treatment with biologicals modify the natural history of comorbidities?
- (2010) Gino A. Vena et al. Dermatologic Therapy
- Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
- (2010) Hideshi Torii et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
- (2010) Akihiko ASAHINA et al. JOURNAL OF DERMATOLOGY
- Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
- (2010) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of psoriasis on health care costs and patient work loss
- (2008) Joseph F. Fowler et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period
- (2007) Andrew A. Nelson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More